|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Kyphon Inc. (Nasdaq: KYPH), a developer of medical devices designed to restore spinal function and diagnose low back pain using minimally invasive technologies. |
|---|---|
| Transferring Party | The spine-related product assets and rights of Disc-O-Tech Medical Technologies, Ltd., an Israeli and U.S. based developer ofnnovative products and IP for performing minimally invasive spine procedures. |
| Sector | Medical Devices |
| Date | December 20, 2006 |
| Analysis Disc-O-Tech's portfolio includes an expandable interbody device for minimally invasive fusion in patients with degenerative disc disease, a system to treat vertebral compression fractures (VCFs) and a cement system. Further extends Kyphon's minimally invasive spine franchise beyond its present technologies for the treatment of VCFs and and diagnosis of the source of low back pain. Kyphon will pay $60m upfront, another $40m upon the earlier of the closing or February 1, 2007, plus a later payment of $120m and an additional $20m upon the the development of further technologies. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |